MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) has announced the development of a language-agnostic AI speech model capable of detecting drug and alcohol intoxication across multiple languages. This advancement aims to provide scalable, non-invasive testing for industries requiring high-volume safety screening, such as mining, aviation, construction, and law enforcement.
The AI prediction model utilizes over 50 million data points to predict alcohol intoxication with high accuracy solely through voice analysis. By integrating this technology into an enterprise platform, MindBio is developing Edge-AI kiosks that combine bespoke hardware and software for detecting drug and alcohol intoxication using the human voice. These kiosks are designed for deployment in various enterprise environments where safety is critical.
This development addresses a significant need for efficient and non-invasive intoxication testing. Traditional methods, such as breathalyzers or blood tests, can be time-consuming and require direct participation. MindBio's voice-based AI model offers a faster, more scalable alternative that could enhance workplace safety and reduce accidents caused by impairment.
For industries like mining, aviation, and construction, where impairment can lead to catastrophic consequences, this technology could provide a proactive safety measure. Law enforcement agencies could also benefit from a non-invasive tool to screen for intoxication during traffic stops or other encounters. The cross-language capability makes it applicable in multilingual regions, broadening its potential impact globally.
The announcement underscores MindBio's commitment to commercializing AI prediction technologies for intoxication detection. The company is positioning itself as a leader in this niche, leveraging a vast dataset and advanced machine learning to improve accuracy. As the technology progresses, it may set new standards for safety screening in high-risk industries.
The full press release is available at https://ibn.fm/PfjuT. For more information about MindBio Therapeutics Corp., including the latest news and updates, visit the company's newsroom at https://ibn.fm/MBQIF.
